ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Kerebrad
|
297 |
87K |
1 |
08:13 |
08:13 |
ASX - By Stock
|
297
|
87K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Kerebrad
|
297 |
87K |
7 |
06:54 |
06:54 |
ASX - By Stock
|
297
|
87K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Kerebrad
|
297 |
87K |
5 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
297
|
87K
|
5
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Quarterly Activities Report
|
|
Kerebrad
|
37 |
14K |
6 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
37
|
14K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
9.5K |
2.8M |
13 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
13
|
|
ASX - By Stock
|
LYC |
Re:
NdPR price
|
|
Kerebrad
|
2.2K |
954K |
6 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
2.2K
|
954K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Kerebrad
|
297 |
87K |
6 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
297
|
87K
|
6
|
|
ASX - By Stock
|
LYC |
Re:
News: LYC Australia's Rinehart takes stake in Lynas Rare Earths
|
|
Kerebrad
|
74 |
34K |
2 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
74
|
34K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
Kerebrad
|
77 |
37K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
77
|
37K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
Kerebrad
|
297 |
87K |
15 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
297
|
87K
|
15
|
|
ASX - By Stock
|
LYC |
Re:
News: LYC Australia's Rinehart takes stake in Lynas Rare Earths
|
|
Kerebrad
|
74 |
34K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
74
|
34K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Kerebrad
|
272 |
113K |
12 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
272
|
113K
|
12
|
|
ASX - By Stock
|
LYC |
Re:
News: LYC Australia's Rinehart takes stake in Lynas Rare Earths
|
|
Kerebrad
|
74 |
34K |
7 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
74
|
34K
|
7
|
|
Charts
|
MSB |
Re:
chart
|
|
Kerebrad
|
31 |
13K |
3 |
17/04/24 |
17/04/24 |
Charts
|
31
|
13K
|
3
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Becoming a substantial holder
|
|
Kerebrad
|
35 |
17K |
13 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
35
|
17K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Shareholder Class Action (VID268/2022) – Notice to Group Members
|
|
Kerebrad
|
168 |
96K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
168
|
96K
|
2
|
|
ASX - By Stock
|
LYC |
Re:
NdPR price
|
|
Kerebrad
|
2.2K |
954K |
7 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
2.2K
|
954K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Kerebrad
|
272 |
113K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
272
|
113K
|
1
|
|
ASX - By Stock
|
LYC |
Re:
Interesting
|
|
Kerebrad
|
95 |
35K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
95
|
35K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Kerebrad
|
554 |
221K |
6 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
554
|
221K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Kerebrad
|
554 |
221K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
554
|
221K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Next price sensitive announcement MSB
|
|
Kerebrad
|
41 |
17K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
41
|
17K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
9.5K |
2.8M |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
9.5K |
2.8M |
8 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
9.5K |
2.8M |
0 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kerebrad
|
9.5K |
2.8M |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
4
|
|
ASX - By Stock
|
LYC |
Re:
Deciphering Lynas
|
|
Kerebrad
|
1.2K |
484K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
1.2K
|
484K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Kerebrad
|
116 |
41K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
116
|
41K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Kerebrad
|
567 |
212K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
567
|
212K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Kerebrad
|
554 |
221K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
554
|
221K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
Kerebrad
|
116 |
41K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
116
|
41K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Kerebrad
|
554 |
221K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
554
|
221K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kerebrad
|
551 |
198K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
551
|
198K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
$1.5/share is closer
|
|
Kerebrad
|
8 |
3.9K |
10 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
8
|
3.9K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Kerebrad
|
554 |
221K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
554
|
221K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Kerebrad
|
554 |
221K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
554
|
221K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Kerebrad
|
5.1K |
2.5M |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Kerebrad
|
272 |
113K |
16 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
272
|
113K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Undervalued Fair value $0.85
|
|
Kerebrad
|
25 |
8.5K |
3 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
25
|
8.5K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kerebrad
|
551 |
198K |
14 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
551
|
198K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Kerebrad
|
554 |
221K |
3 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
554
|
221K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Kerebrad
|
5.1K |
2.5M |
7 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kerebrad
|
551 |
198K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
198K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kerebrad
|
551 |
198K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
198K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kerebrad
|
551 |
198K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
198K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kerebrad
|
551 |
198K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
198K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Kerebrad
|
5.1K |
2.5M |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kerebrad
|
551 |
198K |
10 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
198K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kerebrad
|
551 |
198K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
198K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Kerebrad
|
551 |
198K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
198K
|
5
|
|